The Hemp CBD Market Predicted to Hit $22B by 2022 Recent Report by Brightfield Group
OTTAWA, Sept. 13, 2018 /CNW Telbec/ - LiveWell Canada Inc. ("LiveWell" or the "Company"), (TSXV: LVWL) (OTC: LXLLF), is pleased to announce it is hosting a CBD Hemp Investor Series across Canada in September and October to educate investors on the CBD derived from Industrial Hemp. The Hemp CBD Market is predicted to hit $22B by 2022 according to a new report by Brightfield Group. Hemp CBD Article From Rolling Stone. LiveWell Canada is leading the charge already announcing two Hemp CBD deals with an initial supply and distribution agreement and secured industrial hemp biomass for Canadian CBD products.
LiveWell will be hosting events in the following cities:
- Toronto, ON – Tuesday, September 18th, 2018 12:00 to 1:15 PM EDT
- Montreal, QC – Wednesday September 19th, 2018 - 12:00 PM to 1:15 PM EDT
- Calgary, AB – Tuesday, September 25th, 2018 – 11:15 PM to 12:30 PM MDT
- Vancouver, BC – Wednesday, September 26th, 2018 - 1:15 PM to 2:30 PM PST
- Gatineau, QC & Ottawa, ON – October 3, 2018 4:30 PM to 6:30 PM EDT
RSVP to firstname.lastname@example.org to secure your spot.
The CBD Investor Series will feature presentations by:
Dr. Craig Pearce, anesthesiologist, clinical researcher, and consultant to the Medical Cannabis industry will be discussing the medical benefits of CBD.
Chris Folz J.D., B.A.,B.Ed,Legal Counsel will be discussing the legal aspects of Hemp CBD and the regulatory changes.
David Rendimonti, LiveWell President, who has held senior roles at some of the world's most prominent healthcare organizations such as Johnson & Johnson, Pfizer, and Merck, will be discussing LiveWell's recent developments in Hemp CBD
LiveWell (TSXV:LVWL) is a Hemp & Cannabis company with a focus on CBD listed on the TSXV and partnered with Canopy Growth (TSX:WEED).
Published Hemp CBD White Paper - Read Now
About LiveWell Canada
LiveWell Canada Inc. (TSX-V:LVWL) is an innovative Canadian company planning to become a leader in a new approach to health and wellness by conducting advanced studies on cannabidiol (CBD) and other cannabinoids in its world-class Research and Innovation Centre located in Litchfield, Québec. The company's mission also includes developing and distributing prescription and consumer health products. With more than 1.5 million square feet of greenhouses under construction located in Ontario and Québec, the company is supported by renowned academic and business partners such as Canopy Growth (TSX:WEED,NYSE: CGC) and Canopy Rivers. For more information, visit livewellcorp.com
Cautionary Note Regarding Forward-Looking Statements
This release includes forward-looking statements about the Company and its business. Often, but not always, forward-looking statements can be identified by the use of words such as "plan", "continue", "expect", "schedule", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements (including negative variations) that certain events or conditions "may" or "will" occur. Such statements are based on the current expectations of management. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of unknown and known risk factors and uncertainties affecting the Company, including risks regarding the cannabis and hemp industry, economic factors, the equity markets and risks associated with growth and competition. The Company cautions that this foregoing list of material factors is not exhaustive, and readers are encouraged to read all Risk Factors disclosed in the Company's Filing Statement dated May 29, 2018, as well as the additional risk factors disclosed in the press release dated August 13, 2018.
The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For more information, visit livewellcorp.com
SOURCE LiveWell Canada Inc.
For further information: Media: Stephane Prud'homme, 514-756-9044, email@example.com; Sonya Lord, 866-308-1518, firstname.lastname@example.org; Investors: Nicole Marchand, 416-428-3533, email@example.com